rAj-Tspin, a novel peptide from Apostichopus japonicus, exerts anti-hepatocellular carcinoma effects via the ITGB1/ZYX/FAK/AKT signaling pathway
Authors:
Preprint
- 17 August 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
RAj-Tspin, a soluble gene recombinant peptide from Apostichopus japonicus, can inhibit the integrin β1 (ITGB1)/FAK/AKT signaling pathway in hepatocellular carcinoma (HCC) via cell epithelial–mesenchymal transition (EMT) and apoptosis. Zyxin (ZYX) is a focal adhesion protein that is considered a novel mediator of EMT and apoptosis. However, the inhibitory mechanisms of rAj-Tspin in HCC and whether it is related to ZYX are unclear. We examined the antitumor effect of rAj-Tspin on the Huh7 human HCC cell line and on nude mouse models with subcutaneous injection or orthotopic intrahepatic transplantation of Huh7 cells. Our results show that rAj-Tspin strikingly reduced cell viability and promoted apoptosis in Huh7 cells and inhibited HCC tumor growth in nude mice. rAj-Tspin dose-dependently inhibited ITGB1 and ZYX protein expression in vivo and in vitro. Mechanistically, the FAK/AKT signaling pathway and the proliferation and invasion of HCC cells were suppressed upon ITGB1 and ZYX knockdown. Moreover, the effect of ITGB1 overexpression on the growth of HCC cells could be inhibited by rAj-Tspin. In contrast, the promoting effect of ITGB1 overexpression could be inhibited by ZYX knockdown. ZYX knockdown had no effect on ITGB1 expression. These findings suggest that ZYX is required for the indispensable role of ITGB1 in rAj-Tspin-alleviated HCC and provide an important therapeutic target for HCC. In summary, the anti-HCC effect of rAj-Tspin potentially involves the regulation of the ITGB1/ZYX/FAK/AKT pathway, which in turn impacts EMT and apoptosis.Keywords
All Related Versions
- Version 1, 2023-08-17, Research Square
- Published version: Cancer Cell International, 24 (1), 1.
This publication has 22 references indexed in Scilit:
- A global view of hepatocellular carcinoma: trends, risk, prevention and managementNature Reviews Gastroenterology & Hepatology, 2019
- Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular CarcinomaJAMA Surgery, 2019
- Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinomaJournal of Hepatology, 2019
- RGD cadherins and α2β1 integrin in cancer metastasis: A dangerous liaisonBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2018
- Prognostic value of increased integrin-beta 1 expression in solid cancers: a meta-analysisOncoTargets and Therapy, 2018
- Focal Adhesion–Independent Cell MigrationAnnual Review of Cell and Developmental Biology, 2016
- Focal adhesion signaling and therapy resistance in cancerSeminars in Cancer Biology, 2015
- FAK Is required for c‐Met/β‐catenin‐driven hepatocarcinogenesisHepatology, 2014
- Mechanotransduction at focal adhesions: from physiology to cancer developmentJournal of Cellular and Molecular Medicine, 2013
- Functional analysis of Zyxin in cell migration and invasive potential of oral squamous cell carcinoma cellsInternational Journal of Oncology, 2013